FDA Clearance Tracker · K202215
cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit
Last checked: Nov 20, 2026Latest source record: Sep 2, 2020 (this decision)Source: openFDAMethods & limitations
Decided
Sep 2, 2020
Substantially Equivalent
Time to decision
27 days
Received Aug 6, 2020. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Traditional
Device class
Class II
The decision
- FDA number
- K202215
- Device name
- cobas BKV, cobas EBV/BKV Control Kit, cobas Buffer Negative Control Kit
- Applicant
- Roche Molecular Systems, Inc.
- Applicant location
- Pleasanton, CA
- Received
- Aug 6, 2020
- Decided
- Sep 2, 2020
- Decision
- Substantially Equivalent
- Submission type
- Traditional
Device type
- Device class
- Class II
- Regulation
- 21 CFR 866.3183
- Specialty
- Laboratory Medicine & Pathology
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QMI (Nucleic Acid Amplification Test For The Quantitation Of Bk Virus (Bk) Dna).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
- FDA database record for K202215
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Roche Molecular Systems, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K260045 · Decided Aug 28, 2026 · 233 days after receipt
Device type: C. Difficile Toxin Gene Amplification Assay (OZN) · Laboratory Medicine & Pathology
K260047 · Decided Aug 28, 2026 · 233 days after receipt
Device type: Groups A, C And G Beta-Hemolytic Streptococcus Nucleic Acid Amplification System (PGX) · Laboratory Medicine & Pathology
- cobas® BV/CV510(k)
K260021 · Decided Jul 16, 2026 · 192 days after receipt
Device type: Vaginitis And Bacterial Vaginosis Nucleic Acid Detection System (PQA) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.